Woman in a lab coat with goggles in a snowy mountain setting.

Future of Health

Discover how Switzerland can be your gateway to the European life sciences market.

1
 st place

Switzerland leads in talent competitiveness, followed by Singapore, the United States, Denmark, and the Netherlands

$ 
116
 bn

In 2023, life sciences—including pharmaceuticals, vitamins, and diagnostics—made up 38.5% of Swiss exports

Top 
10

Switzerland ranks 10th worldwide for the number of active biotech patents within its territory

Switzerland offers seamless market access, top talent, and a business-friendly ecosystem. 20 percent of European Life Science companies have already chosen Switzerland as their HQ location. Find out how Switzerland can help you scale and thrive in Europe.

Swiss Biotech Day 2027

Key Visual SBD 2027

Global Village 

Switzerland Global Enterprise is delighted to partner again with the Swiss Biotech Association and organize the Side Visits Program for the international delegations of the Global Village, taking place on Wednesday, 28 April 2027, following the Swiss Biotech Day (26-27 April 2027). Further details about the program will be announced in February 2027. Discover more about the Global Village participation packages, associated benefits and deadlines.

Why Switzerland

Modern laboratory with microscope, computer screen showing graphs, and test tubes.

Ecosystem

Develop partnerships to scale your business

The Swiss life science ecosystem is made up of innovative start-ups and multinational giants such as Roche, Novartis, Bayer, Abbott, Merck, Biogen, CSL Behring, Baxter, Johnson & Johnson, Hamilton, and Medtronic. These companies benefit from Switzerland’s experienced cluster along the entire value chain to develop, produce and market new products and services - from drug discovery to commercialization, all in one place. 

If you are looking to set up supply chain and other headquarter functions, Switzerland provides excellent infrastructure and solutions for managing revenues and risks.

Scientist in a lab coat working with glass containers and tubing.

Regulatory

Enjoy a safe and innovative legal framework

Considering European expansion? Life Science companies favor Switzerland as a headquarter location for many reasons. Its central location, various trade agreements and progressive regulations make it easy for companies to tap into the European market, made up of almost 500 million consumers. A business-friendly environment and competitive corporate and personal tax rates provide further advantages for setting up headquarter functions in Switzerland. 20% of European Life Science companies have already chosen Switzerland as their HQ location, representing over 90 companies with active clinical trials. Life Science companies that already settled in Switzerland include Bluebird Bio, Roivant Sciences, BeiGene, Alnylam, Incyte, Biogen, Moderna, Luye Pharma, Align Technology, and Amgen.

Laboratory technician using a pipette on a microscope slide.

Innovation

Collaborate pragmatically with leading research institutes

Switzerland’s strong collaboration between science and industry accelerates the path from lab to market. In a 2021 analysis by Biotechgate, Switzerland has the strongest product pipeline in Europe, after the UK. With CHF 9 billion invested by pharma alone in 2020, and two-thirds of all R&D spending coming from private firms, Switzerland ranks among the top globally in R&D intensity.  14 Swiss companies are ranked among the top 500 companies worldwide in terms of corporate research spending, with Roche ranked in 8th position and Novartis in 14th position.

Learn how your company can benefit from Switzerland’s unique focus on applied science.

Medical professional in blue scrubs operates equipment, focused on a screen.

Talent

Attract and retain the best people

Benefit from Switzerland’s talent pool - because it’s vast! Switzerland is a hub for PhD professionals in Life Sciences and related disciplines, with its top-ranking universities attracting diverse doctoral talent. Switzerland provides a rich talent pool for pharmaceutical, biotechnology, medical technology and digital health.  Switzerland's excellent quality of life, favorable tax policies and flexible work arrangements make it an attractive destination for C-level executives. Its renowned apprenticeship system ensures well-trained lab technicians or QC analysts with practical skills for the highly regulated life sciences sector and biologics manufacturing processes.

Find out more about talent in the Swiss health industry. 

The Canton of Zug has proved ideal for our international headquarters. Its central location, transit connections, and modern infrastructure are essential for our business. The natural beauty and quality of life have helped us attract and retain outstanding talent.

Woman in a dark suit with short hair, serious expression, blurred background.

Dr. Katja Buller

Vice President and Head of Corporate Affairs International, Biogen

Testimonials

Read what peers have achieved in Switzerland.

In focus

Switzerland: where global pharma players meet startups

Sub-Technologies

Switzerland provides a conducive business environment which fosters scientific excellence. Its strong research ecosystem, skilled talent pool, and collaborative culture have been instrumental in supporting our innovation journey. Our presence here continues to play an important role in advancing our research capabilities and driving scientific progress.

Anurag Mantri, Executive Director & Global Chief Financial Officer, Glenmark Pharmaceuticals

News

Keep up to date

Read more

Publications

Download more resources

Contact

Man in a dark suit smiling, standing before a geometric white cube background.

David Dixon

Senior Consultant - Investment Promotion

Renens, Switzerland

ddixon@s-ge.com

+41 21 545 94 98

Log in or register

Enter your email to continue.

Exclusive access for companies based in Switzerland or the Principality of Liechtenstein.